Remove Marketing Remove Medical science Remove Pharmacology
article thumbnail

How to Become a Pharmaceutical Sales Representative

Pharmaceutical Representative Training

Next, pharma reps need to have a strong foundation in basic science and pharmacology. Pharmacology is the science of medications and the role they play in the body. Can you easily connect with others? If so, you might have the makings of a great pharmaceutical sales representative.

article thumbnail

Pharmaceutical Sales Training: Mastering the Art of Modern Pharma Sales

Contrarian Sales Techniques

Regulation changes, like the introduction of the Prescription Drug Marketing Act in the 1980s, brought about a more structured approach. Whether it's adjusting to new market trends, shifting healthcare policies, or evolving customer needs, being able to pivot and adapt your approach is essential.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why R&D innovation holds the key to greater patient impact

European Pharmaceutical Review

The growing issue of inequitable access is not just an issue of developing or emerging countries either; significant disparities in medicine availability exist within Europe where the time between regulatory approval (marketing authorisation) and true access for patients can vary from a few days to 2.5

Patients 105
article thumbnail

Recurrent drug shortages signal onerous outlook for cardiovascular care

Pharmaceutical Technology

Genentech, a subsidiary of Roche , markets alteplase and tenecteplase under the names Activase and TNKase in the US, while Boehringer sells them under the names Actilyse and Metalyse in the EU. But these substitutions do not come without complications, as these drugs can vary in their pharmacologic properties, states Page.

Medicine 111
article thumbnail

Innovations in Cancer Research & Treatment: Leveraging Modern Technologies to Overcome Global Challenges

PM360

The global telemedicine market is projected to reach USD 396.76 The broader challenge in drug development is the staggering failure rate: of the compounds that begin as discovery projects, only about 10% make it to clinical trials, and of those, only 10% succeed in reaching the market. billion by 2027, growing at a CAGR of 25.8%.